The A. Alfred Taubman Medical Research Institute supports some of today’s most aggressive medical science researchers with three-year grants that they use to fund their laboratories and scientific investigations. Our current roster includes eight Taubman Scholars, four Emerging Scholars and four senior Taubman Scholars in their second round of funding.
The Taubman Scholars
The Taubman Scholars are senior level scientists at the University of Michigan Medical School, who are doing discovery-driven research.
Their laboratory teams are working to combat a wide array of diseases: childhood and adult cancer, diabetes, ALS, cardiovascular disease, obesity, diabetes and many other debilitating diseases.
Scholars also serve as advocates for research by taking part in U-M efforts to educate the public about the importance of biomedical research and the need to provide support for scientific study.
Nicholas Boulis, M.D.
Frank C. Brosius III, M.D.
Charles F. Burant, M.D., Ph.D.
Arul M. Chinnaiyan, M.D., Ph.D.
Thomas Gardner, M.D., M.S.
David Ginsburg, M.D.
Theodore Lawrence, M.D., Ph.D.
Kenneth J. Pienta, M.D.
Senior Taubman Scholars
Through the progress of their research and their public stewardship of the cause of medical science, these former Taubman Scholars have earned renewed funding.
Emerging Taubman Scholars
The Emerging Scholars Program provides support for clinician scientists on the U-M faculty who are in the early stages of their research careers.
There is a pressing need in the scientific community to do more to support early-career researchers who are increasingly choosing to leave the laboratory. We are at risk of losing the next generation of our best and brightest scientists.
The Emerging Scholars Program offers an opportunity for them to establish their credentials in order to secure traditional funding in the future.
Ronald J. Buckanovich, M.D., Ph.D.
James Dowling, M.D., Ph.D.
Katherine Gallagher, M.D.
Johann E. Gudjonsson, M.D., Ph.D.
Alon Kahana, M.D., Ph.D.
Erika A. Newman, M.D.
Parag Patil, M.D., Ph.D.
Sung Won Choi, M.D.
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
- June 14, 2013
- June 05, 2013
- May 31, 2013
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.